Latest Content

Long-awaited progress in rectal and gastric cancer research includes a fast track designation and new survival data.

CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.

A young cancer survivor who underwent EBRT and brachytherapy at 14 discusses her rare diagnosis, side effects, and the non-link to her Turner syndrome.

The U.S. FDA has granted orphan drug designation to M2T-CD33 for the treatment of patients with acute myeloid leukemia.

Basal cell carcinoma, or BCC, is the most common form of skin cancer globally, but it is also highly curable.

This is an essential guide on stage 2 cervical cancer to support patients in discussing diagnosis, treatment, and care decisions with their oncology team.

Learn how HR-positive/HER2-negative breast cancer is diagnosed, treated by stage and managed for side effects to guide patient-oncologist discussions.

An 11-year survivor of stage 4 breast cancer explains that everyone has a role to play.

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay chemotherapy and radiation.

As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and resources for liver cancer.

A cancer survivor explains how humor helped her during her cancer journeys.

CURE spoke with Dr. Rosario Ligestri and Dr. Anna Berkenblit about the rising rate of pancreatic cancer in relatively younger adults.